Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyper-IgM Syndrome”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Large-scale testing (Phase 3)Study completedNCT01963143
What this trial is testing

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinaemia+1 more
Bio Products Laboratory 48
Early research (Phase 1)WithdrawnNCT00224354
What this trial is testing

Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells

Who this might be right for
CHRONIC LYMPHOCYTIC B-LEUKEMIA
Baylor College of Medicine
Large-scale testing (Phase 3)Study completedNCT00278954
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Who this might be right for
Primary ImmunodeficiencyCommon Variable HypogammaglobulinemiaX-linked Hypogammaglobulinemia+3 more
Bio Products Laboratory 50
Not applicableUnknownNCT02974192
What this trial is testing

Neopterin Effects on Ischemic Stroke

Who this might be right for
Stroke
Assiut University 100
Not applicableUnknownNCT00008749
What this trial is testing

Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Looking for participantsNCT06305286
What this trial is testing

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Who this might be right for
Type 1 Diabetes Mellitus
University of Chicago 70
Testing effectiveness (Phase 2)Study completedNCT00730314
What this trial is testing

Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Sickle Cell DiseaseThalassemiaAnemia+9 more
Children's Hospital Los Angeles 25
Not applicableEnded earlyNCT00266513
What this trial is testing

Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

Who this might be right for
Hyper-IgM SyndromeEctodermal Dysplasia
National Institute of Allergy and Infectious Diseases (NIAID) 119
Testing effectiveness (Phase 2)WithdrawnNCT00504322
What this trial is testing

Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma

Who this might be right for
Esophageal Neoplasms
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Early research (Phase 1)Study completedNCT00458679
What this trial is testing

Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Baylor College of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT00053391
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University Hospital Erlangen 62
Post-approval studies (Phase 4)Study completedNCT01289847
What this trial is testing

Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinemia+2 more
Bio Products Laboratory 25
Testing effectiveness (Phase 2)Study completedNCT02320357
What this trial is testing

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

Who this might be right for
Systemic Lupus Erythematous
University Hospital, Bordeaux 18
Early research (Phase 1)Study completedNCT00078520
What this trial is testing

Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells

Who this might be right for
LeukemiaLeukemia, B-Cell, Chronic
Baylor College of Medicine 9
Not applicableStudy completedNCT05059431
What this trial is testing

The Effect of Human Prostate Tissue on Platelet Activation

Who this might be right for
Prostate HyperplasiaCoagulation; IntravascularThrombotic Disorder
Tri-Service General Hospital 8
Large-scale testing (Phase 3)Study completedNCT01884311
What this trial is testing

Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinaemia+1 more
Bio Products Laboratory 38
Load More Results